<DOC>
	<DOCNO>NCT00490828</DOCNO>
	<brief_summary>Hydrocortisone show improve early outcome high risk patient cardiac surgery . A potential mechanism result effect may immunomodulatory action . In prospective interventional study hypothesis proven .</brief_summary>
	<brief_title>Influence Hydrocortisone Immunologic Markers Health Care Related Quality Life Patients After Cardiac Surgery</brief_title>
	<detailed_description>Methods : Prospective interventional randomize double blind placebo control study . Intervention : Hydrocortisone stress dos vs. placebo Patients : 92 high risk patient cardiac surgery Measurements : Cytokines , Toll-like receptor , NF kappa B , outcome data , health care relate quality life , PTSD .</detailed_description>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Preoperative leave ventricular ejection fraction 39 % duration extracorporeal circulation 97 min Pregnancy Severe liver insufficiency Severe renal insufficiency Insulin dependent diabetes mellitus Steroid therapy Psychiatric disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Cardiac surgery</keyword>
	<keyword>systemic inflammatory response syndrome</keyword>
	<keyword>health-related quality life</keyword>
</DOC>